Merrimack Pharmaceuticals, Cambridge MA

Merrimack Pharmaceuticals (NASDAQ:MACK)is a bio-pharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. Merrimack’s mission is to provide patients, physicians and the healthcare system with the tools, medicines and information to transform the approach to care from one based on the identification and treatment of symptoms to one focused on the diagnosis and treatment of illness through a more precis e mechanistic understanding of disease. Merrimack seeks to accomplish this mission by applying its proprietary systems biology-based approach to biomedical research, an approach the company calls Network Biology. Merrimack’s vision is to apply Network Biology to become a global health care enterprise that is founded on leading science and driven to deliver integrated healthcare solutions that improve both the quality of patient outcomes and the efficiency of care.